Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease (Cannabis-SCD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2014 by University of California, San Francisco.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
University of Minnesota - Clinical and Translational Science Institute
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01771731
First received: January 14, 2013
Last updated: August 6, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)